Disclosures for "Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a Newborn"
-
Dr. Varnet has nothing to disclose.
-
Dr. Kayani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogene. The institution of Dr. Kayani has received research support from Neurogene. The institution of Dr. Kayani has received research support from NIH.
-
Dr. Wang has nothing to disclose.